SlideShare a Scribd company logo
Dr. Amita Jain

Consultant
Urogynaecologist
Medanta Institute of Kidney & Urology
Medanta -The Medicity
Gurgaon, Haryana -122001, INDIA
 Irreversible binding
to the presynaptic
membrane, producing
a long-lasting paralytic
effect.
 Action dose- and
site-specific, may take
24–48 hrs to exert its
effects.

Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited


Neuropathic bladder conditions
◦ Detrusor overactivity
◦ Detrusor sphincter dysenergia



Bladder overactivity



Painful bladder syndrome



Pelvic pain



Outflow obstruction symptoms



Urinary retention
Intradetrusor injection of BTx was approved in 2011
by FDA for neurogenic detrusor overactivity only,
but the off-label use is increasingly common.
Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
9 ½ Years girl
K/C of Langerhan’s Histocytosis ( on & off steroids)
PRESENTING COMPLAINTS (March 2009)
 Recurrent UTI
 Nocturnal Enuresis
 Daytime incontinence
 Difficulty in passing urine
PAST H/O
 Gross haematuria in 2009 (USG KUB / CECT - mild diffuse
thickening of bladder wall ?Cystitis)
 CPE +urethral dilatation in 2010 (DMSA/ DRCG/KFT – WNL)
 Protenuria suggestive of ? Ig A Nephropathy/ Nephrotic
Syndrome
PHYSICAL EXAMINATION Normal

Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited


Micturating cystourethrogram (2010)- no reflux, no
urethral obstruction



MRI Spine - normal



USG KUB - B/L mild HUN, persisting post void
Thickened & irregular bladder wall
PVR 126 cc

Failed trial of antimuscarinics & alpha blockers,
biofeedback and other conservative management.
Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Sensation

-2 cmH2O

48 cc

29 cmH2O

Normal
desire

70 cc

43 cmH2O

Strong desire

91 cc

159 cmH2O

Max cyst
capacity

91 cc

158 cmH2O

180 cc
71 cc

Peak flow rate

21 cc

First desire

Voided volume

Pdet

First
sensation

Total bladder capacity

Bladder
filling

3 ml/s

Pdet at peak flow

8 cmH2O

Average flow rate

3 ml/s

Residual Urine

109 ml

Opening Pdet

12
cmH2O

Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Refractory idiopathic
detrusor overactivity with
superimposed
dysfunctional voiding
(non-neuropathic bladdersphincter dysfunction )

Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Sensation

7 cmH2O

84 cc

14 cmH2O

Normal desire

88 cc

16 cmH2O

Strong desire

110 cc

32 cmH2O

Max cyst
capacity

110 cc

33 cmH2O

110 cc
73 cc

Peak flow rate

42 cc

First desire

Voided volume

Pdet

First
sensation

Total bladder capacity

Bladder
filling

6 ml/s

Pdet at peak flow

33 cmH2O

Average flow rate

3 ml/s

Residual Urine

37 ml

Opening Pdet

24 cmH2O
Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
48 years librarian
K/C of Interstitial Cystitis Dx on Cystoscopy + bladder biopsy
(2/8/10)
PRESENTING COMPLAINTS (May 2011)
 Severe dysuria
 Frequent urination
 Feeling of incomplete emptying of bladder
 Poor flows
PAST H/O
 Urethral dilatation in 2000
 Failed conservative ( lifestyle & diet modification), medical
management (Amitryptalline/PMSO) and Intravesical
instillation therapies
Dr Amita Jain

Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Sensation

2 cmH2O

65 cc

2 cmH2O

Normal desire

79 cc

2 cmH2O

Strong desire

88 cc

3 cmH2O

Max cyst
capacity

104 cc

5 cmH2O

106 cc
55 cc

Peak flow rate

59 cc

First desire

Voided volume

Pdet

First sensation

Total bladder capacity

Bladder
filling

3 ml/s

Pdet at peak flow

19 cmH2O

Average flow rate

2 ml/s

Residual Urine

51 ml

Opening Pdet

15 cmH2O

Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Painful bladder Syndrome/IC
(hypersensitive low capacity
bladder)

Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited


200 units diluted with
20mls of normal saline



Given as 1 ml
injections at 20
different sites
including trigone*

Fig. 1. Injection technique for BoNT into the overactive bladder
Dae Kyung Kim et al Urol Clin N Am 33 (2006) 503-510

*Kuo HC (2011) Bladder base/trigone injection is safe and as effective as
bladder body injection of onabotulinumtoxinA for idiopathic detrusor
overactivity refractory to antimuscarinics. Neurourol Urodyn 30:1242–1248
*Pinto R et al (2010) Trigonal injection of botulinum toxin A in patients with
refractory bladder pain syndrome/interstitial cystitis. Eur Urol. Sep;58(3):360-5
Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited


Minor effects (Karsenty et al, 2008)

◦
◦
◦
◦
◦

most frequent
injection site pain
procedure-related urinary tract infection
mild hematuria
Increase in PVR



Severe effects (Systemic)

◦
◦
◦
◦
◦
◦

Very rare
Drug reaction - rash of a flu- like illness
Nausea, vomitting
dysphagia, diplopia, blurred vision
Mouth & respiratory weakness
periheral muscle weakness



Contraindications

◦ pre-existing neuromuscular conditions

Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited










Linda Brubaker et al (2012) Treatment satisfaction and goal attainment
with onabotulinumtoxinA in patients with incontinence due to idiopathic
OAB Int Urogynecol J 23:1017–1025
Denys P et al (2012) Efficacy and Safety of Low Doses of
OnabotulinumtoxinA for the Treatment of Refractory Idiopathic Overactive
Bladder: A Multicentre, Double-Blind, Randomised, Placebo-Controlled
Dose-Ranging Study. Eur Urol 61:520–529
Rovner E et al (2011) Urodynamic results and clinical outcomes with
intradetrusor injections of onabotulinumtoxin A in a randomized, placebocontrolled dose-finding study in idiopathic overactive bladder. Neurourol
Urodyn 30:556–562
Duthie JB et al (2011) Botulinum toxin injections for adults with overactive
bladder syndrome. Cochrane Database Syst Rev (12):CD005493
Dmochowski R et al (2010) Efficacy and safety of onabotulinumtoxinA for
idiopathic overactive bladder: a double-blind, placebo controlled,
randomized, dose ranging trial. J Urol 184:2416–2422

Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited


Shiu-Dong Chung et al (2012) Intravesical
OnabotulinumtoxinA Injections for Refractory Painful Bladder
Syndrome. Pain Physician; 15:197-202 • ISSN 1533-3159



Giannantoni A et al (2008) Botulinum A toxin intravesical
injection in patients with painful bladder syndrome: 1-year
followup. J Urol ; 179:1031- 1034.



Giannantoni A et al(2006) Botulinum A toxin intravesical
injections in the treatment of painful bladder syndrome: A
pilot study. Eur Urol ; 49:704-709.
Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited


No universally accepted dose and technique.



Exact targeted depth of injection remains controversial.



Promising alternative option for varied indications in
future.

Thanks
Dr Amita Jain
Confidential & Proprietary
Any use of material without prior permission is strictly prohibited
Medanta Institute of Kidney & Urology

Dr. Amita Jain
Urogynaecology Clinic
12th Floor, OPD Wing,
Medanta -The Medicity
Gurgaon, Haryana -122001, INDIA
Tel: +91 124 4141 414 info@medanta.org www.medanta.org
MOB. +91-9871136110
http://www.urogynecologistindia.in/
http://amitajainurogynaecolgist.blogspot.in/
http://www.linkedin.com/mbox?displayMBoxItem=&itemID=I225857003_75

More Related Content

What's hot

Bleeding in first trimester
Bleeding in first trimesterBleeding in first trimester
Bleeding in first trimesterdrmcbansal
 
Female sterilisation
Female sterilisationFemale sterilisation
Female sterilisation
Labeeb Pc
 
Septic abortion
Septic abortionSeptic abortion
Septic abortion
adityakushmi
 
Fistula and Conflict: Reproductive Health in East Democratic Republic of Congo
Fistula and Conflict: Reproductive Health in East Democratic Republic of CongoFistula and Conflict: Reproductive Health in East Democratic Republic of Congo
Fistula and Conflict: Reproductive Health in East Democratic Republic of Congo
i-ACT
 
Management of ectopic pregnancy
Management of ectopic pregnancyManagement of ectopic pregnancy
Management of ectopic pregnancy
Medaramitla Sadhana reddy
 
VVF DR SR PATANAIK
VVF DR SR PATANAIKVVF DR SR PATANAIK
VVF DR SR PATANAIK
Smruti Patanaik
 
Obstetric fistula
Obstetric fistulaObstetric fistula
Obstetric fistula
kayasa07
 
03 genital fistula isam
03 genital fistula isam03 genital fistula isam
03 genital fistula isam
Isamaldin Elamin
 
Common gyne. op
Common gyne. opCommon gyne. op
Common gyne. op
tariggally
 
Ectopic pregnancy
Ectopic pregnancyEctopic pregnancy
Ectopic pregnancy
Arya Anish
 
SURGICAL MANAGEMENT OF SEPTIC ABORTION
SURGICAL MANAGEMENT OF SEPTIC ABORTIONSURGICAL MANAGEMENT OF SEPTIC ABORTION
SURGICAL MANAGEMENT OF SEPTIC ABORTION
Dr.Nehal Vaidya
 
Uterine balloon tamponade in Postpartum Hemorrhage (PPH)
Uterine balloon tamponade in Postpartum Hemorrhage (PPH)Uterine balloon tamponade in Postpartum Hemorrhage (PPH)
Uterine balloon tamponade in Postpartum Hemorrhage (PPH)
Mahantesh Karoshi
 
Obstetrics fistula
Obstetrics fistulaObstetrics fistula
genito urinary fistula
 genito urinary fistula genito urinary fistula
genito urinary fistula
yashar22
 
Ectopic Pregnancy – Early Diagnosis and Management
Ectopic Pregnancy – Early Diagnosis and ManagementEctopic Pregnancy – Early Diagnosis and Management
Ectopic Pregnancy – Early Diagnosis and Management
Dr Manavita Mahajan
 
Obstetric fistulae
Obstetric fistulaeObstetric fistulae
Obstetric fistulae
SREEVIDYA UMMADISETTI
 
Group 4 Reproductive System
Group 4 Reproductive SystemGroup 4 Reproductive System
Group 4 Reproductive Systemshenell delfin
 
Vesico vaginal fistula
Vesico vaginal fistulaVesico vaginal fistula
Vesico vaginal fistula
Urology Department MTI LRH peshawar.
 
Fistula genitourinaria. Ginecologia. UMSNH.
Fistula genitourinaria. Ginecologia. UMSNH.Fistula genitourinaria. Ginecologia. UMSNH.
Fistula genitourinaria. Ginecologia. UMSNH.
David Linares González
 

What's hot (20)

Bleeding in first trimester
Bleeding in first trimesterBleeding in first trimester
Bleeding in first trimester
 
Female sterilisation
Female sterilisationFemale sterilisation
Female sterilisation
 
Septic abortion
Septic abortionSeptic abortion
Septic abortion
 
Fistula and Conflict: Reproductive Health in East Democratic Republic of Congo
Fistula and Conflict: Reproductive Health in East Democratic Republic of CongoFistula and Conflict: Reproductive Health in East Democratic Republic of Congo
Fistula and Conflict: Reproductive Health in East Democratic Republic of Congo
 
Management of ectopic pregnancy
Management of ectopic pregnancyManagement of ectopic pregnancy
Management of ectopic pregnancy
 
VVF DR SR PATANAIK
VVF DR SR PATANAIKVVF DR SR PATANAIK
VVF DR SR PATANAIK
 
Obstetric fistula
Obstetric fistulaObstetric fistula
Obstetric fistula
 
03 genital fistula isam
03 genital fistula isam03 genital fistula isam
03 genital fistula isam
 
Common gyne. op
Common gyne. opCommon gyne. op
Common gyne. op
 
Ectopic pregnancy
Ectopic pregnancyEctopic pregnancy
Ectopic pregnancy
 
SURGICAL MANAGEMENT OF SEPTIC ABORTION
SURGICAL MANAGEMENT OF SEPTIC ABORTIONSURGICAL MANAGEMENT OF SEPTIC ABORTION
SURGICAL MANAGEMENT OF SEPTIC ABORTION
 
Uterine balloon tamponade in Postpartum Hemorrhage (PPH)
Uterine balloon tamponade in Postpartum Hemorrhage (PPH)Uterine balloon tamponade in Postpartum Hemorrhage (PPH)
Uterine balloon tamponade in Postpartum Hemorrhage (PPH)
 
Obstetrics fistula
Obstetrics fistulaObstetrics fistula
Obstetrics fistula
 
genito urinary fistula
 genito urinary fistula genito urinary fistula
genito urinary fistula
 
Ectopic Pregnancy – Early Diagnosis and Management
Ectopic Pregnancy – Early Diagnosis and ManagementEctopic Pregnancy – Early Diagnosis and Management
Ectopic Pregnancy – Early Diagnosis and Management
 
Obstetric fistulae
Obstetric fistulaeObstetric fistulae
Obstetric fistulae
 
Group 4 Reproductive System
Group 4 Reproductive SystemGroup 4 Reproductive System
Group 4 Reproductive System
 
Vesico vaginal fistula
Vesico vaginal fistulaVesico vaginal fistula
Vesico vaginal fistula
 
Fistula genitourinaria. Ginecologia. UMSNH.
Fistula genitourinaria. Ginecologia. UMSNH.Fistula genitourinaria. Ginecologia. UMSNH.
Fistula genitourinaria. Ginecologia. UMSNH.
 
Ectopic pregnancy 1
Ectopic pregnancy   1Ectopic pregnancy   1
Ectopic pregnancy 1
 

Viewers also liked

Project on the centre for incontinence & neurourology
Project on the centre for incontinence & neurourology Project on the centre for incontinence & neurourology
Project on the centre for incontinence & neurourology
Parvez Pathan
 
Ürojinekoloji - www.jinekolojivegebelik.com
Ürojinekoloji - www.jinekolojivegebelik.comÜrojinekoloji - www.jinekolojivegebelik.com
Ürojinekoloji - www.jinekolojivegebelik.com
jinekolojivegebelik.com
 
Glup montecchio diagnosi urodinamica semplificata-torino_vignoli
Glup montecchio diagnosi urodinamica semplificata-torino_vignoliGlup montecchio diagnosi urodinamica semplificata-torino_vignoli
Glup montecchio diagnosi urodinamica semplificata-torino_vignoli
GLUP2010
 
Botulinum toxin in urology2
Botulinum toxin in urology2Botulinum toxin in urology2
Botulinum toxin in urology2
anchal8203
 
Urodynamic studies for neurogenic bladder
Urodynamic studies for neurogenic bladderUrodynamic studies for neurogenic bladder
Urodynamic studies for neurogenic bladder
Mohammed Abd El Wadood
 
Urodinamia
UrodinamiaUrodinamia
Dr hassaan...(OAB)
Dr hassaan...(OAB)Dr hassaan...(OAB)
Overactive bladder
Overactive bladderOveractive bladder
Overactive bladder
Ramayya Pramila
 
Urodinamica abc
Urodinamica abcUrodinamica abc
Urodinamica abcGLUP2010
 
STRESS URINARY INCONTINENCE
STRESS URINARY INCONTINENCESTRESS URINARY INCONTINENCE
STRESS URINARY INCONTINENCE
Fazly Shakoor
 
Prostatic cancer
Prostatic cancerProstatic cancer
Prostatic cancer
Ajai Sasidhar
 
Bph 4th yr
Bph 4th yrBph 4th yr
Bph 4th yr
Musfirah Tahir
 
Urodynamics /Uroflowmetry
Urodynamics /UroflowmetryUrodynamics /Uroflowmetry
Urodynamics /Uroflowmetry
Ramayya Pramila
 
Voiding dysfunction A Simple Approach Towards Understanding and Management - ...
Voiding dysfunction A Simple Approach Towards Understanding and Management - ...Voiding dysfunction A Simple Approach Towards Understanding and Management - ...
Voiding dysfunction A Simple Approach Towards Understanding and Management - ...
Mohammed Abd El Wadood
 
Obstructive uropathy+urolithias
Obstructive uropathy+urolithiasObstructive uropathy+urolithias
Obstructive uropathy+urolithias
Soumya Ranjan Parida
 
Gonorrea
GonorreaGonorrea
Gonorrea
mary0407
 
Overactive bladder
Overactive bladderOveractive bladder
Overactive bladder
Dr. Preksha Jain
 
Urology finalized
Urology finalizedUrology finalized
Urology finalized
Shan Nathan
 
Urinary Outflow Obstruction
Urinary Outflow ObstructionUrinary Outflow Obstruction
Urinary Outflow ObstructionDr Harim Mohsin
 

Viewers also liked (20)

Project on the centre for incontinence & neurourology
Project on the centre for incontinence & neurourology Project on the centre for incontinence & neurourology
Project on the centre for incontinence & neurourology
 
Ürojinekoloji - www.jinekolojivegebelik.com
Ürojinekoloji - www.jinekolojivegebelik.comÜrojinekoloji - www.jinekolojivegebelik.com
Ürojinekoloji - www.jinekolojivegebelik.com
 
Glup montecchio diagnosi urodinamica semplificata-torino_vignoli
Glup montecchio diagnosi urodinamica semplificata-torino_vignoliGlup montecchio diagnosi urodinamica semplificata-torino_vignoli
Glup montecchio diagnosi urodinamica semplificata-torino_vignoli
 
Urodinamia
UrodinamiaUrodinamia
Urodinamia
 
Botulinum toxin in urology2
Botulinum toxin in urology2Botulinum toxin in urology2
Botulinum toxin in urology2
 
Urodynamic studies for neurogenic bladder
Urodynamic studies for neurogenic bladderUrodynamic studies for neurogenic bladder
Urodynamic studies for neurogenic bladder
 
Urodinamia
UrodinamiaUrodinamia
Urodinamia
 
Dr hassaan...(OAB)
Dr hassaan...(OAB)Dr hassaan...(OAB)
Dr hassaan...(OAB)
 
Overactive bladder
Overactive bladderOveractive bladder
Overactive bladder
 
Urodinamica abc
Urodinamica abcUrodinamica abc
Urodinamica abc
 
STRESS URINARY INCONTINENCE
STRESS URINARY INCONTINENCESTRESS URINARY INCONTINENCE
STRESS URINARY INCONTINENCE
 
Prostatic cancer
Prostatic cancerProstatic cancer
Prostatic cancer
 
Bph 4th yr
Bph 4th yrBph 4th yr
Bph 4th yr
 
Urodynamics /Uroflowmetry
Urodynamics /UroflowmetryUrodynamics /Uroflowmetry
Urodynamics /Uroflowmetry
 
Voiding dysfunction A Simple Approach Towards Understanding and Management - ...
Voiding dysfunction A Simple Approach Towards Understanding and Management - ...Voiding dysfunction A Simple Approach Towards Understanding and Management - ...
Voiding dysfunction A Simple Approach Towards Understanding and Management - ...
 
Obstructive uropathy+urolithias
Obstructive uropathy+urolithiasObstructive uropathy+urolithias
Obstructive uropathy+urolithias
 
Gonorrea
GonorreaGonorrea
Gonorrea
 
Overactive bladder
Overactive bladderOveractive bladder
Overactive bladder
 
Urology finalized
Urology finalizedUrology finalized
Urology finalized
 
Urinary Outflow Obstruction
Urinary Outflow ObstructionUrinary Outflow Obstruction
Urinary Outflow Obstruction
 

Similar to Botulinum toxin – indications still to be explored

Botox
BotoxBotox
Tossina botulinica: indicazioni, risultati e limiti
Tossina botulinica: indicazioni, risultati e limiti Tossina botulinica: indicazioni, risultati e limiti
Tossina botulinica: indicazioni, risultati e limiti
GLUP2010
 
Botulinum toxin in Urology
Botulinum toxin in UrologyBotulinum toxin in Urology
Botulinum toxin in Urology
Apollo Hospitals
 
ANTIEMETICS AND PROKINETIC AGENTS
ANTIEMETICS AND PROKINETIC AGENTSANTIEMETICS AND PROKINETIC AGENTS
ANTIEMETICS AND PROKINETIC AGENTSanujrims
 
14. Ptq Injections For Faecal Incontinence
14. Ptq Injections For Faecal Incontinence14. Ptq Injections For Faecal Incontinence
14. Ptq Injections For Faecal Incontinenceensteve
 
Taking Control of Urinary Incontinence
Taking Control of Urinary IncontinenceTaking Control of Urinary Incontinence
Taking Control of Urinary Incontinence
Affinity Health System
 
antiemetic (1).pptx
antiemetic (1).pptxantiemetic (1).pptx
antiemetic (1).pptx
HassamZulfiqar1
 
2 vertin
2  vertin 2  vertin
2 vertin
social service
 
Benign prostatic hyperplasia
Benign prostatic hyperplasiaBenign prostatic hyperplasia
Benign prostatic hyperplasia
sukhpreetkaur142
 
Benign Prostate Hyperplasia (BPH)
Benign Prostate Hyperplasia (BPH)Benign Prostate Hyperplasia (BPH)
Benign Prostate Hyperplasia (BPH)
Cikbungazafieya Zawani
 
Current Approach to Overactive Bladder, Issues & Management by Prof. Haleema ...
Current Approach to Overactive Bladder, Issues & Management by Prof. Haleema ...Current Approach to Overactive Bladder, Issues & Management by Prof. Haleema ...
Current Approach to Overactive Bladder, Issues & Management by Prof. Haleema ...
Usman Hingoro
 
3 vertin clinical trials
3  vertin clinical trials3  vertin clinical trials
3 vertin clinical trials
social service
 
Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...
Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...
Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...
Lifecare Centre
 
Urinary antiseptic
Urinary antisepticUrinary antiseptic
Urinary antiseptic
Sayali Powar
 
Iuga adly ebm
Iuga adly ebmIuga adly ebm
Iuga adly ebm
budi1
 
Uro gynacology- botox
Uro gynacology- botoxUro gynacology- botox
Uro gynacology- botox
GovtRoyapettahHospit
 
Sudden kombinasi th(2) dr.fikri
Sudden   kombinasi th(2) dr.fikriSudden   kombinasi th(2) dr.fikri
Sudden kombinasi th(2) dr.fikri
Suharti Wairagya
 
Diagnostic studies of gi system.pptx
Diagnostic studies of gi system.pptxDiagnostic studies of gi system.pptx
Diagnostic studies of gi system.pptx
Beema3
 
PNDT AND MTP ACT.pptx
PNDT AND MTP ACT.pptxPNDT AND MTP ACT.pptx
PNDT AND MTP ACT.pptx
Sparsha Kelaginamane
 

Similar to Botulinum toxin – indications still to be explored (20)

Botox
BotoxBotox
Botox
 
Tossina botulinica: indicazioni, risultati e limiti
Tossina botulinica: indicazioni, risultati e limiti Tossina botulinica: indicazioni, risultati e limiti
Tossina botulinica: indicazioni, risultati e limiti
 
Botulinum toxin in Urology
Botulinum toxin in UrologyBotulinum toxin in Urology
Botulinum toxin in Urology
 
ANTIEMETICS AND PROKINETIC AGENTS
ANTIEMETICS AND PROKINETIC AGENTSANTIEMETICS AND PROKINETIC AGENTS
ANTIEMETICS AND PROKINETIC AGENTS
 
14. Ptq Injections For Faecal Incontinence
14. Ptq Injections For Faecal Incontinence14. Ptq Injections For Faecal Incontinence
14. Ptq Injections For Faecal Incontinence
 
Taking Control of Urinary Incontinence
Taking Control of Urinary IncontinenceTaking Control of Urinary Incontinence
Taking Control of Urinary Incontinence
 
antiemetic (1).pptx
antiemetic (1).pptxantiemetic (1).pptx
antiemetic (1).pptx
 
2 vertin
2  vertin 2  vertin
2 vertin
 
Benign prostatic hyperplasia
Benign prostatic hyperplasiaBenign prostatic hyperplasia
Benign prostatic hyperplasia
 
Benign Prostate Hyperplasia (BPH)
Benign Prostate Hyperplasia (BPH)Benign Prostate Hyperplasia (BPH)
Benign Prostate Hyperplasia (BPH)
 
Current Approach to Overactive Bladder, Issues & Management by Prof. Haleema ...
Current Approach to Overactive Bladder, Issues & Management by Prof. Haleema ...Current Approach to Overactive Bladder, Issues & Management by Prof. Haleema ...
Current Approach to Overactive Bladder, Issues & Management by Prof. Haleema ...
 
3 vertin clinical trials
3  vertin clinical trials3  vertin clinical trials
3 vertin clinical trials
 
Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...
Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...
Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...
 
Urinary antiseptic
Urinary antisepticUrinary antiseptic
Urinary antiseptic
 
Iuga adly ebm
Iuga adly ebmIuga adly ebm
Iuga adly ebm
 
Uro gynacology- botox
Uro gynacology- botoxUro gynacology- botox
Uro gynacology- botox
 
Sudden kombinasi th(2) dr.fikri
Sudden   kombinasi th(2) dr.fikriSudden   kombinasi th(2) dr.fikri
Sudden kombinasi th(2) dr.fikri
 
Diagnostic studies of gi system.pptx
Diagnostic studies of gi system.pptxDiagnostic studies of gi system.pptx
Diagnostic studies of gi system.pptx
 
PNDT AND MTP ACT.pptx
PNDT AND MTP ACT.pptxPNDT AND MTP ACT.pptx
PNDT AND MTP ACT.pptx
 
Periset.ppt
Periset.pptPeriset.ppt
Periset.ppt
 

Recently uploaded

Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 

Recently uploaded (20)

Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 

Botulinum toxin – indications still to be explored

  • 1. Dr. Amita Jain Consultant Urogynaecologist Medanta Institute of Kidney & Urology Medanta -The Medicity Gurgaon, Haryana -122001, INDIA
  • 2.  Irreversible binding to the presynaptic membrane, producing a long-lasting paralytic effect.  Action dose- and site-specific, may take 24–48 hrs to exert its effects. Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 3.  Neuropathic bladder conditions ◦ Detrusor overactivity ◦ Detrusor sphincter dysenergia  Bladder overactivity  Painful bladder syndrome  Pelvic pain  Outflow obstruction symptoms  Urinary retention Intradetrusor injection of BTx was approved in 2011 by FDA for neurogenic detrusor overactivity only, but the off-label use is increasingly common. Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 4. 9 ½ Years girl K/C of Langerhan’s Histocytosis ( on & off steroids) PRESENTING COMPLAINTS (March 2009)  Recurrent UTI  Nocturnal Enuresis  Daytime incontinence  Difficulty in passing urine PAST H/O  Gross haematuria in 2009 (USG KUB / CECT - mild diffuse thickening of bladder wall ?Cystitis)  CPE +urethral dilatation in 2010 (DMSA/ DRCG/KFT – WNL)  Protenuria suggestive of ? Ig A Nephropathy/ Nephrotic Syndrome PHYSICAL EXAMINATION Normal Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 5.  Micturating cystourethrogram (2010)- no reflux, no urethral obstruction  MRI Spine - normal  USG KUB - B/L mild HUN, persisting post void Thickened & irregular bladder wall PVR 126 cc Failed trial of antimuscarinics & alpha blockers, biofeedback and other conservative management. Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 6. Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 7. Sensation -2 cmH2O 48 cc 29 cmH2O Normal desire 70 cc 43 cmH2O Strong desire 91 cc 159 cmH2O Max cyst capacity 91 cc 158 cmH2O 180 cc 71 cc Peak flow rate 21 cc First desire Voided volume Pdet First sensation Total bladder capacity Bladder filling 3 ml/s Pdet at peak flow 8 cmH2O Average flow rate 3 ml/s Residual Urine 109 ml Opening Pdet 12 cmH2O Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 8. Refractory idiopathic detrusor overactivity with superimposed dysfunctional voiding (non-neuropathic bladdersphincter dysfunction ) Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 9. Sensation 7 cmH2O 84 cc 14 cmH2O Normal desire 88 cc 16 cmH2O Strong desire 110 cc 32 cmH2O Max cyst capacity 110 cc 33 cmH2O 110 cc 73 cc Peak flow rate 42 cc First desire Voided volume Pdet First sensation Total bladder capacity Bladder filling 6 ml/s Pdet at peak flow 33 cmH2O Average flow rate 3 ml/s Residual Urine 37 ml Opening Pdet 24 cmH2O Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 10. 48 years librarian K/C of Interstitial Cystitis Dx on Cystoscopy + bladder biopsy (2/8/10) PRESENTING COMPLAINTS (May 2011)  Severe dysuria  Frequent urination  Feeling of incomplete emptying of bladder  Poor flows PAST H/O  Urethral dilatation in 2000  Failed conservative ( lifestyle & diet modification), medical management (Amitryptalline/PMSO) and Intravesical instillation therapies Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 11. Sensation 2 cmH2O 65 cc 2 cmH2O Normal desire 79 cc 2 cmH2O Strong desire 88 cc 3 cmH2O Max cyst capacity 104 cc 5 cmH2O 106 cc 55 cc Peak flow rate 59 cc First desire Voided volume Pdet First sensation Total bladder capacity Bladder filling 3 ml/s Pdet at peak flow 19 cmH2O Average flow rate 2 ml/s Residual Urine 51 ml Opening Pdet 15 cmH2O Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 12. Painful bladder Syndrome/IC (hypersensitive low capacity bladder) Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 13. Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 14.  200 units diluted with 20mls of normal saline  Given as 1 ml injections at 20 different sites including trigone* Fig. 1. Injection technique for BoNT into the overactive bladder Dae Kyung Kim et al Urol Clin N Am 33 (2006) 503-510 *Kuo HC (2011) Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics. Neurourol Urodyn 30:1242–1248 *Pinto R et al (2010) Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol. Sep;58(3):360-5 Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 15. Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 16.  Minor effects (Karsenty et al, 2008) ◦ ◦ ◦ ◦ ◦ most frequent injection site pain procedure-related urinary tract infection mild hematuria Increase in PVR  Severe effects (Systemic) ◦ ◦ ◦ ◦ ◦ ◦ Very rare Drug reaction - rash of a flu- like illness Nausea, vomitting dysphagia, diplopia, blurred vision Mouth & respiratory weakness periheral muscle weakness  Contraindications ◦ pre-existing neuromuscular conditions Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 17.      Linda Brubaker et al (2012) Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB Int Urogynecol J 23:1017–1025 Denys P et al (2012) Efficacy and Safety of Low Doses of OnabotulinumtoxinA for the Treatment of Refractory Idiopathic Overactive Bladder: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Dose-Ranging Study. Eur Urol 61:520–529 Rovner E et al (2011) Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxin A in a randomized, placebocontrolled dose-finding study in idiopathic overactive bladder. Neurourol Urodyn 30:556–562 Duthie JB et al (2011) Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev (12):CD005493 Dmochowski R et al (2010) Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol 184:2416–2422 Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 18.  Shiu-Dong Chung et al (2012) Intravesical OnabotulinumtoxinA Injections for Refractory Painful Bladder Syndrome. Pain Physician; 15:197-202 • ISSN 1533-3159  Giannantoni A et al (2008) Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. J Urol ; 179:1031- 1034.  Giannantoni A et al(2006) Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study. Eur Urol ; 49:704-709. Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 19.  No universally accepted dose and technique.  Exact targeted depth of injection remains controversial.  Promising alternative option for varied indications in future. Thanks Dr Amita Jain Confidential & Proprietary Any use of material without prior permission is strictly prohibited
  • 20. Medanta Institute of Kidney & Urology Dr. Amita Jain Urogynaecology Clinic 12th Floor, OPD Wing, Medanta -The Medicity Gurgaon, Haryana -122001, INDIA Tel: +91 124 4141 414 info@medanta.org www.medanta.org MOB. +91-9871136110 http://www.urogynecologistindia.in/ http://amitajainurogynaecolgist.blogspot.in/ http://www.linkedin.com/mbox?displayMBoxItem=&itemID=I225857003_75

Editor's Notes

  1. Localized administration produces chemical denervation by irreversible binding to the presynaptic membrane, producing a long-lasting paralytic effect. The toxin may take 24–48 h to exert its effects. After 3–6 months, the axons regenerate, thus reversing the denervation process. The toxin is dose- and site-specific. The duration of effect will vary considerably depending on how it is used.
  2. Detrusor external sphincter dyssynergia Detrusor hyperreflexia (neurogenic detrusor activity) Spastic conditions of the urethral rhabdosphincter (non-relaxing sphincter) Chronic prostatic pain (and pelvic floor spasticity) Interstitial cystitis, motor and sensory urge incontinence Non-fibrotic bladder outflow obstruction (including treatment of benign prostatic hyperplasia) Detrusor underactivity and acute urinary retention in women